Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$1.26 USD

1.26
49,639,300

+0.07 (5.88%)

Updated Sep 18, 2025 04:00 PM ET

After-Market: $1.26 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sweta Killa headshot

Will Q4 Results Continue to Fuel Momentum in Marijuana ETF?

by Sweta Killa

Investors are keenly watching whether legalization is living up to the hype in the quarterly results of the cannabis stocks.

Sanghamitra Saha headshot

Buy the Dip in Marijuana Stocks & ETF?

by Sanghamitra Saha

Marijuana stocks and ETF slumped on Feb 6. Is this the time to buy?

Tracey Ryniec headshot

Where to Find the Best Marijuana Stocks

by Tracey Ryniec

As the marijuana industry gets more complex, check out the Zacks Market Edge Podcast where host Tracey Ryniec

Sanghamitra Saha headshot

Pot Stocks are on a High: Play These Marijuana ETFs

by Sanghamitra Saha

As marijuana stocks soar into the new year, which ETFs should investors consider?

Zacks Equity Research

The Zacks Analyst Blog Highlights: Cronos, Altria, Canopy and Tilray

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Cronos, Altria, Canopy and Tilray

Ryan McQueeney headshot

Here's Why Cannabis Stocks (ACB, CRON) Are Gaining Today

by Ryan McQueeney

Shares of several notable cannabis stocks, including Aurora Cannabis (ACB) and Cronos Group (CRON), were up more than 10% through early afternoon trading hours Monday.

Zacks Equity Research

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $81.91 in the latest trading session, marking a +1.76% move from the prior day.

Sanghamitra Saha headshot

What Makes Marijuana ETF the Best Performer in January?

by Sanghamitra Saha

These are the factors that led marijuana ETF to see a strong start to 2019.

Zacks Equity Research

Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $71.74, marking a -1.46% move from the previous day.

Ryan McQueeney headshot

Earnings from Netflix & Big Banks, & This Week in Cannabis Deals

by Ryan McQueeney

Ryan McQueeney and Maddy Johnson discuss earnings results from Netflix and the big U.S. banks. The hosts also remember the legacy of Jack Bogle and chat about several new cannabis industry deals.

Zacks Equity Research

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

by Zacks Equity Research

Tilray (TLRY) needs investors to pay close attention to the stock based on moves in the options market lately.

Zacks Equity Research

Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Zacks Equity Research

Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos

by Zacks Equity Research

Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos

Zacks Equity Research

Intrexon Signs Licensing Agreement with Next Green Wave

by Zacks Equity Research

Intrexon (XON) partners with Next Green Wave Holdings to utilize Intrexon's Botticelli next-generation plant propagation platform.

Ryan McQueeney headshot

A Week of Cannabis Investing Deals & Earnings Reports from GS, BAC, UAL

by Ryan McQueeney

Ryan McQueeney covers the latest Brexit news and Snap's executive exodus. He also recaps earnings results from Goldman Sachs, Bank of America, and United Air Lines. Later, he discusses a busy week for deals in the cannabis industry.

Zacks Equity Research

Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off

by Zacks Equity Research

Tilray (TLRY) signs a marketing agreement with Authentic Brands Group to sell consumer cannabis products.

Ryan McQueeney headshot

Why Did Tilray (TLRY) Stock Drop Sharply Today?

by Ryan McQueeney

Shares of Tilray (TLRY) fell more than 17% on Tuesday after its post-IPO lockup period expired, allowing early investors in the Canadian marijuana company to cash out of their positions for the first time.

David Borun headshot

Tilray's Tuesday Slide Due to IPO Lockup Expiration

by David Borun

Tilray's biggest shareholder resolves to stay long for the foreseeable future

Zacks Equity Research

Tilray Shares Rally as Investor Plans Not to Sell Shares

by Zacks Equity Research

Tilray (TLRY) gains after Privateer Holdings decides not to sell shares in the first half of 2019.

Zacks Equity Research

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed the most recent trading day at $80.40, moving +0.88% from the previous trading session.

Zacks Equity Research

Zacks Market Edge Highlights: Tilray, Constellation Brands, Altria and GW Pharmaceuticals

by Zacks Equity Research

Zacks Market Edge Highlights: Tilray, Constellation Brands, Altria and GW Pharmaceuticals

Tracey Ryniec headshot

Pot Stocks in 2019: A Year of Transition

by Tracey Ryniec

In 2018, investors pinned their pot stock hopes on Canadian legalization but in 2019 the game has changed. Who will emerge as the winners?

Zacks Equity Research

Softness in Beer Hurt Alcohol Stocks, Can Cannabis Change Fate?

by Zacks Equity Research

The alcohol space continues its struggles against soft beer sales and higher costs. Meanwhile, cannabis-infused drinks are gaining popularity.

Zacks Equity Research

Tilray Gains More Than 200%: Is There More Scope for Growth?

by Zacks Equity Research

Tilray (TLRY) gains more than 200% in the past six months. Strategic deals should propel further growth.

Zacks Equity Research

Tilray, Inc. (TLRY) Stock Moves -0.65%: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $70, marking a -0.65% move from the previous day.